The U.S. Food and Drug Administration building behind FDA logos at a bus stop on the agency’s campus ... Staffers said a similar policy was communicated to reviewers who handle vaccines, biotech drugs ...

Learn more about whether Legend Biotech Corporation or Moderna, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

Learn more about whether Alvotech or Legend Biotech Corporation is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

In a report released on April 3, Leonid Timashev from RBC Capital maintained a Buy rating on Legend Biotech (LEGN – Research Report), with a ...

Shares of Legend Biotech Co. (NASDAQ:LEGN – Get Free Report) hit a new 52-week low during mid-day trading on Monday . The company traded as low as $29.31 and last traded at $30.15, with a volume of ...

Day One Biopharmaceuticals (NASDAQ:DAWN – Get Free Report) and Legend Biotech (NASDAQ:LEGN – Get Free Report) are both medical companies, but which is the better investment? We will compare the two ...

According to Benzinga Pro, Legend Biotech's peer group average for short interest as a percentage of float is 10.75%, which ...

Legend Biotech's Carvykti shows strong efficacy in multiple myeloma as U.S.-based manufacturing shields it from tariffs and global regulatory risks.

Analysts' ratings for Legend Biotech (NASDAQ:LEGN) over the last quarter vary from bullish to bearish, as provided by 5 analysts. The following table encapsulates their recent ratings, offering a ...

5 analysts have shared their evaluations of Legend Biotech (NASDAQ:LEGN) during the recent three months, expressing a mix of bullish and bearish perspectives. The table below summarizes their ...

The company's cancer cell therapy Carvykti, which it makes in partnership with Legend Biotech, brought in sales of $369 million, above estimates of $324 million. Quarterly sales of J&J's cancer drugs ...